Abstract:Vascular endothelial cells produce various biologically active factors regulating blood pressure, coagulation, and possibly cell growth of the vascular wall. Of the factors, nitric oxide (NO) has been the object of attention because of its quite simple molecular structure and variety of biological functions. In the present review, we focused on the physiologic and pathologic aspects of NO in hypertension. In experimental animals, both acute and chronic inhibition of NO synthase (NOS) with arginine derivatives produce a significant rise in blood pressure, indicating that tonic production of NO regulates basal vascular tonus. The chronic hypertension caused by NOS inhibitor is associated with cardiac hypertrophy and renal insufficiency. Sodium retention, though transient, and the plasma and tissue renin/angiotensin system in addition to the reduced production of NO have been implicated in the development of hypertension. Hypertension and the associated target organ failure can be reversed by co-administration of L-arginine or blockades of the renin/angiotensin system. Studies in which L-arginine as the substrate of NO or NOS inhibitor was administered demonstrated an important role of NO in the regulation of tonic vascular tonus also in normal subjects. In hypertensive subjects, however, endothelium-dependent vasorelaxation and production of NO are impaired, possibly due to a deficiency of L-arginine and/or a disorder of its utilization. Recent advances in the methods of detecting NO enabled us to demonstrate its diminished production from endothelial cells of hypertensive rats in vitro, although no definite biochemical evidence has been obtained in hypertensive subjects. The endothelial dysfunction, however, is not a primary cause of hypertension but a secondary result since it is commonly observed in various types of hypertension and can be reversed by correcting the blood pressure. Other common diseases including atherosclerosis and diabetes mellitus are also associated with similar abnormalities of the endothelium. NO has anti-atherogenic actions: inhibition of platelet functions and proliferation of vascular smooth muscle cells. Therefore, potentiation of endogenous NO and/or supplement of exogenous NO donors could be novel therapeutic approaches for the treatment of hypertension and atherosclerosis, while potential adverse effects of NO including cytotoxicity, immunosuppressibility, and hypotensive shock should be taken into account.

Short-Term NO Synthase Inhibition and the Na+-Binding Properties of Cardiac Na,K-ATPase

Chronic Disturbances in NO Production Results in Histochemical and Subcellular Alterations of the Rat Heart

Nitric Oxide-Compromised Hypertension: Facts and Enigmas

Nitric Oxide Regulation of Myocardial O2 Consumption and HEP Metabolism.

[PP.11.11] ADAPTIVE VASOACTIVE PROPERTIES OF THORACIC AORTA IN YOUNG NORMOTENSIVE AND SPONTANEOUSLY HYPERTENSIVE RATS

Effect of Captopril on Cyclic Nucleotide Concentrations During Long-Term NO Synthase Inhibition

[Dynamin-Mediated Endocytic Process Contributes to Neuronal Nitric Oxide Synthase-Mediated Regulation of Cardiac Contraction].

Long-Term Administration of D-NAME Induces Hemodynamic and Structural Changes in the Cardiovascular System

The Role of Inos-Derived NO in the Antihypertrophic Actions of B-type Natriuretic Peptide in Neonatal Rat Cardiomyocytes

Inhibition of endogenous nitric oxide synthase potentiates nitrovasodilators in experimental pulmonary hypertension

Modulation of Baroreflex Activity by Exogenous and Endogenous NO in SD Rats

Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes

Nitric Oxide Protects Cardiac Sarcolemmal Membrane Enzyme Function and Ion Active Transport Against Ischemia-Induced Inactivation

Myofilament Ca2 + Desensitization Mediates Positive Lusitropic Effect of Neuronal Nitric Oxide Synthase in Left Ventricular Myocytes from Murine Hypertensive Heart

Relationship of angiotensinase and vasopressinase activities between hypothalamus, heart, and plasma in L-NAME-treated WKY and SHR

Effect of antihypertensive agents - captopril and nifedipine - on the functional properties of rat heart mitochondria

[Clinical significance of nitric oxide in hypertension]

Sacubitril/Valsartan Alleviates Cardiac Remodeling and Dysfunction in L-NAME-Induced Hypertension and Hypertensive Heart Disease

Influence of Atp-Sensitive K+ Channel Modulation on the Mechanical Properties of Diabetic Myocardium

Effects of Pharmacological Inhibitors of NADPH Oxidase on Myogenic Contractility and Evoked Vasoactive Responses in Rat Resistance Arteries

Natriuretic peptides stimulate the cardiac sodium pump via NPR-C-coupled NOS activation